Skip to content
healthcare.dev

Naproxen Sodium

NDC 62207-729, Naproxen Sodium, tablet, from Granules India Ltd.

Product NDC
62207-729
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-729 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
62207-729-246220707292424 TABLET in 1 BOTTLE (62207-729-24)
62207-729-426220707294250 TABLET in 1 BOTTLE (62207-729-42)
62207-729-4362207072943100 TABLET in 1 BOTTLE (62207-729-43)
62207-729-4762207072947500 TABLET in 1 BOTTLE (62207-729-47)
62207-729-49622070729491000 TABLET in 1 BOTTLE (62207-729-49)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-729 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-729 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-729. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.